As a founding member of the World Health Organization (WHO), the United States of America has served as a cornerstone of global public health for decades, contributing significantly to monumental achievements that have reshaped human history. From the successful eradication of smallpox to ongoing, concerted efforts against polio, HIV/AIDS, Ebola, influenza, tuberculosis, and the rising threat of antimicrobial resistance, the partnership between the U.S. and the WHO has historically been viewed as a primary driver of global stability. Consequently, the World Health Organization has officially expressed profound regret regarding the United States’ notification of withdrawal—a move that global health experts warn could compromise the safety and health security of both the American population and the international community at large.
The formal notification of withdrawal triggers a complex procedural phase. These issues are slated for comprehensive review by the WHO Executive Board during its session beginning February 2, followed by deeper deliberation at the annual World Health Assembly in May 2026. This administrative transition marks a significant shift in the landscape of multilateral health cooperation, raising critical questions about the future of global disease surveillance, funding, and international solidarity.
The Anatomy of the Diplomatic Rift
The friction between the U.S. government and the WHO centers primarily on the management of the COVID-19 pandemic. The U.S. administration has leveled serious allegations against the agency, asserting that the WHO “trashed and tarnished” its reputation, compromised its institutional independence, and failed in its duty to provide objective, timely information during the onset of the global health crisis. Specifically, the U.S. government argued that the WHO “concealed” failures and obstructed the flow of critical information during the early months of 2020.
The WHO, however, has issued a rigorous rebuttal to these claims, maintaining that it acted with transparency and urgency. The agency asserts that while no entity, including national governments, performed flawlessly in the face of an unprecedented global threat, its response was dictated strictly by the best available scientific evidence. The WHO points out that its advisory role throughout the pandemic emphasized public health measures—such as masking and physical distancing—rather than the imposition of mandates. The agency maintains that it respected the sovereignty of nations to determine their own internal policies, viewing its role as that of a technical advisor rather than a regulatory authority.
Chronology of the Initial COVID-19 Response
To address the accusations of delay, the WHO has provided a detailed timeline of its actions in the early days of the COVID-19 pandemic, emphasizing its adherence to the International Health Regulations (IHR).
- December 31, 2019: Following reports of a cluster of “pneumonia of unknown cause” in Wuhan, China, the WHO activated its emergency incident management system and formally requested further information from Chinese authorities.
- January 11, 2020: As the first death was reported in China, the WHO had already utilized global public channels, including social media and formal diplomatic networks, to alert the international community.
- January 30, 2020: The WHO Director-General declared COVID-19 a Public Health Emergency of International Concern (PHEIC). At this juncture, there were fewer than 100 reported cases and zero deaths outside of China, signaling a proactive, rather than reactive, stance under international health law.
During the initial months of 2020, the WHO leadership repeatedly emphasized the urgency of the situation, characterizing the virus as “public enemy number one” and warning member states that the window for global containment was rapidly narrowing.
Evaluating Institutional Performance and Reform
In the aftermath of the acute phase of the pandemic, the WHO has undergone multiple independent reviews regarding its performance. In response to these findings, the agency has implemented systemic reforms aimed at bolstering both its internal agility and the preparedness capacities of its member states. These systems, which now operate on a 24/7 basis, are designed to ensure that global health threats are identified and mitigated before they escalate into regional or international catastrophes.
Despite claims from the U.S. that the organization has been captured by a “politicized, bureaucratic agenda driven by nations hostile to American interests,” the WHO maintains that its governance structure—comprised of 194 member states—ensures total impartiality. As a specialized agency of the United Nations, the WHO operates under a mandate to serve all nations equitably, emphasizing that its focus remains on scientific integrity rather than geopolitical alignment.
Global Health Impact and Future Cooperation
The implications of the U.S. withdrawal extend far beyond administrative friction. The WHO remains a vital platform for the negotiation of international law regarding pandemic preparedness. Most notably, member states recently adopted the WHO Pandemic Agreement, a landmark instrument currently undergoing ratification. This agreement aims to formalize international obligations during future outbreaks, ensuring that the world is better prepared for the next zoonotic spillover or respiratory threat.
Furthermore, ongoing negotiations regarding the "Pathogen Access and Benefit Sharing" (PABS) system seek to create a framework for the rapid, equitable sharing of data and resources, including vaccines, therapeutics, and diagnostics. The absence of the United States—historically a primary financier and scientific contributor to these initiatives—could significantly alter the dynamics of these negotiations and the efficacy of future implementation.
The Role of Scientific Collaboration
Beyond the high-level diplomatic disputes, the daily function of the WHO involves technical cooperation that often goes unnoticed by the public. This includes the Global Influenza Surveillance and Response System (GISRS), which monitors viral evolution worldwide, and the management of neglected tropical diseases that continue to affect hundreds of millions of people globally.
Data from the WHO indicates that the organization’s reach is extensive. Through its regional offices and country-level teams, the WHO provides the infrastructure for vaccine distribution, maternal health programs, and nutritional monitoring in conflict zones and developing nations. The United States has historically been a critical partner in these efforts, providing technical expertise and substantial financial support that has historically leveraged greater contributions from other nations.
Looking Toward the Future
While the current diplomatic environment is strained, the WHO has expressed a persistent hope that the United States will eventually return to active, full-scale participation. The agency frames its mission as a fundamental right—the highest attainable standard of health for all people—and argues that this mission is impossible to achieve without the robust, collaborative involvement of all major world powers.
As the Executive Board meeting approaches in February and the World Health Assembly looms in 2026, the international community faces a critical juncture. The outcome of these discussions will likely determine the architecture of global health security for the coming decades. For now, the WHO continues to function, managing ongoing crises and preparing for future ones, while signaling a readiness to engage with the United States in good faith, maintaining that its constitutional mandate remains unchanged regardless of the political currents flowing through its member states.
The divergence between Washington and Geneva underscores a broader global challenge: the struggle to balance national sovereignty with the realities of an interconnected world where biological threats do not respect international borders. As the international health community watches these developments, the focus remains on whether a path can be found to reconcile the concerns of the United States with the collective, multilateral interests that the World Health Organization was founded to protect.
